SARS-CoV-2 bivalent mRNA vaccine with broad protection against variants of concern.
Frontiers in immunology(2023)
摘要
Our data suggest that RBMRNA-405 is a promising bivalent SARS-CoV-2 vaccine with broad-spectrum efficacy for further clinical development.
更多查看译文
关键词
SARS-CoV-2, bivalent mRNA vaccine, variants of concern (VOCs), immunogenicity, broad-spectrum efficacy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要